IGF-II gene region polymorphisms related to exertional muscle damage

Journal of Applied Physiology

Volumn 102, Issue 5, 2007, Pages 1815-1823

  Devaney, Joseph M ^a   Hoffman, Eric P ^a   Gordish Dressman, Heather ^a   Kearns, Amy ^c   Zambraski, Edward ^b   Clarkson, Priscilla M ^b,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Insulin like growth factor II; Single nucleotide polymorphism

Indexed keywords

CREATINE KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3;

AMINO ACID SEQUENCE; ARTICLE; CHROMATIN; CHROMOSOME 11; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ISOTONIC EXERCISE; MALE; MUSCLE INJURY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; COHORT STUDIES; CREATINE KINASE, MM FORM; EXERCISE; EXERTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LINKAGE DISEQUILIBRIUM; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOGLOBIN; PAIN; PAIN MEASUREMENT; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 34247849178     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01165.2006     Document Type: Article

References (47)

1. Adams GR. Autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol 93: 1159-1167, 2002.
2. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL Jr, Urban RJ. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280: E383-E390, 2001.
3. Casas-Carrillo E, Prill-Adams A, Price SG, Clutter AC, Kirkpatrick BW. Relationship of growth hormone and insulin-like growth factor-1 genotypes with growth and carcass traits in swine. Anim Genet 28: 88-93, 1997.
4. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 99: 154-163, 2005.
5. Clarkson PM, Hoffman EP, Zambraski E, Gordish-Dressman H, Kearns A, Hubal M, Harmon B, Devaney JM. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol 99: 564-569, 2005.
6. Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 81: S52-69, 2002.
7. Clarkson PM, Kearns AK, Rouzier P, Rubin R, Thompson PD. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 38: 623-627, 2006.
8. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Olesen JL, Suetta C, Teisner B, Kjaer M. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol 558: 333-340, 2004.
9. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 6: 287-312, 2005.
10. Dreyer HC, Blanco CE, Sattler FR, Schroeder ET, Wiswell RA. Satellite cell numbers in young and older men 24 hours after eccentric exercise. Muscle Nerve 2005.
11. Evans WJ, Cannon JG. The metabolic effects of exercise-induced muscle damage. Exerc Sport Sci Rev 19: 99-125, 1991.
12. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulinlike growth factor system in myogenesis. Endocr Rev 17: 481-517, 1996.
13. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 10: 1491-1501, 2001.
14. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol 161: 2263-2272, 2002.
15. Gregorevic P, Plant DR, Lynch GS. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve 30: 295-304, 2004.
16. Haugk KL, Roeder RA, Garber MJ, Schelling GT. Regulation of muscle cell proliferation by extracts from crushed muscle. J Anim Sci 73: 1972-1981, 1995.
17. International HapMap Consortium. A haplotype map of the human genome. Nature 437: 1299-1320, 2005.
18. Keller HL, St Pierre Schneider B, Eppihimer LA, Cannon JG. Association of IGF-I and IGF-II with myofiber regeneration in vivo. Muscle Nerve 22: 347-354, 1999.
19. Kinugawa S, Tsutsui H, Ide T, Nakamura R, Arimura K, Egashira K, Takeshita A. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res 43: 157-164, 1999.
20. Kostek MC, Delmonico MJ, Reichel JB, Roth SM, Douglass L, Ferrell RE, Hurley BF. Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults. J Appl Physiol 98: 2147-2154, 2005.
21. Kotlyar AA, Vered Z, Goldberg I, Chouraqui P, Nas D, Fridman E, Chen-Levy Z, Fytlovich S, Sangiorgi G, Spagnoli LG, Orlandi A, Savion N, Eldar M, Scheinowitz M. Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart 86: 693-700, 2001.
22. Lee HJ, Kim KJ, Park MH, Kimm K, Park C, Oh B, Lee JY. Single-nucleotide polymorphisms and haplotype LD analysis of the 29-kb IGF2 region on chromosome 11p15.5 in the Korean population. Hum Hered 60: 73-80, 2005.
23. Lee J, Clarkson PM. Plasma creatine kinase activity and glutathione after eccentric exercise. Med Sci Sports Exerc 35: 930-936, 2003.
24. Levinovitz A, Jennische E, Oldfors A, Edwall D, Norstedt G. Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation. Mol Endocrinol 6: 1227-1234, 1992.
25. Lieber RL, Friden J. Morphologic and mechanical basis of delayed-onset muscle soreness. J Am Acad Orthop Surg 10: 67-73, 2002.
26. Marsh DR, Criswell DS, Hamilton MT, Booth FW. Association of insulin-like growth factor mRNA expressions with muscle regeneration in young, adult, and old rats. Am J Physiol Regul Integr Comp Physiol 273: R353-R358, 1997.
27. McLoon LK, Christiansen SP. Increasing extraocular muscle strength with insulin-like growth factor II. Invest Ophthalmol Vis Sci 44: 3866-3872, 2003.
28. Nezer C, Moreau L, Brouwers B, Coppieters W, Detilleux J, Hanset R, Karim L, Kvasz A, Leroy P, Georges M. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 21: 155-156, 1999.
29. Nosaka K, Clarkson PM. Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sports Exerc 28: 953-961, 1996.
30. Nosaka K, Clarkson PM. Variability in serum creatine kinase response after eccentric exercise of the elbow flexors. Int J Sports Med 17: 120-127, 1996.
31. Nosaka K, Clarkson PM, Apple FS. Time course of serum protein changes after strenuous exercise of the forearm flexors. J Lab Clin Med 119: 183-188, 1992.
32. O'Dell SD, Day IN. Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30: 767-771, 1998.
33. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE, Day IN. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 21: 822-825, 1997.
34. Okutsu T, Kuroiwa Y, Kagitani F, Kai M, Aisaka K, Tsutsumi O, Kaneko Y, Yokomori K, Surani MA, Kohda T, Kaneko-Ishino T, Ishino F. Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem (Tokyo) 127: 475-483, 2000.
35. Proske U, Morgan DL. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537: 333-345, 2001.
36. Rodriguez S, Gaunt TR, O'Dell SD, Chen XH, Gu D, Hawe E, Miller GJ, Humphries SE, Day IN. Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Hum Mol Genet 13: 715-725, 2004.
37. Roth SM, Schrager MA, Lee MR, Metter EJ, Hurley BF, Ferrell RE. Interleukin-6 (IL6) genotype is associated with fat-free mass in men but not women. J Gerontol A Biol Sci Med Sci 58: B1085-B1088, 2003.
38. Sanes JR, Schachner M, Covault J. Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle. J Cell Biol 102: 420-431, 1986.
39. Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, Briggs R, Day IN, Cooper C. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 31: 468-470, 2002.
40. Schrager MA, Roth SM, Ferrell RE, Metter EJ, Russek-Cohen E, Lynch NA, Lindle RS, Hurley BF. Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J Appl Physiol 97: 2176-2183, 2004.
41. Spangenburg EE, Abraha T, Childs TE, Pattison JS, Booth FW. Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent. Am J Physiol Endocrinol Metab 284: E340-E350, 2003.
42. Stone EA, Cooper GM, Sidow A. Trade-offs in detecting evolutionarily constrained sequence by comparative genomics. Annu Rev Genomics Hum Genet 6: 143-164, 2005.
43. Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L, Archibald AL, Haley CS, Buys N, Tally M, Andersson G, Georges M, Andersson L. A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 425: 832-836, 2003.
44. Vu TH, Chuyen NV, Li T, Hoffman AR. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res 63: 1900-1905, 2003.
45. Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med 27: 43-59, 1999.
46. Wilson EM, Rotwein P. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281: 29962-29971, 2006.
47. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73: 627-631, 2003.